3D CAMERAS ACQUISITIONS FOR THE DOCUMENTATION OF CULTURAL HERITAGE

Abstract. Photography has always been considered as a valid tool to acquire information about reality. Nowadays, its versatility, together with the development of new techniques and technologies, allows to use it in different fields of application. Particularly, in the digitization of built heritage, photography not only enables to understand and document historical and architectural artifacts but also to acquire morphological and geometrical data about them with automated digital photogrammetry. Nowadays, photogrammetry enables many tools to give virtual casts of reality by showing it in the way of point cloud. Although they can have metric reliability and visual quality, traditional instruments &amp;ndash; such as monoscopic cameras &amp;ndash; involve a careful planning of the campaign phase and a long acquisition and processing time. On the contrary, the most recent ones, based on the integration of different sensors and cameras, try to reduce the gap between time and results. The latter include some systems of indoor mapping who, thanks to 360&amp;deg; acquisitions and SLAM technology, reconstruct the original scene in real time in great detail and with a photorealistic rendering. This study is aimed at reporting a research evaluating metric reliability and the level of survey detail with a Matterport Pro2 3D motorized rotating camera, equipped with SLAM technology, whose results have been compared with point clouds obtained by image-based and range-based processes.</p

Toll-like receptor kinetics in septic shock patients: a preliminary study.

The aim of this study is to evaluate some inflammatory parameter changes in septic shock patients and their possible correlation with clinical outcome, in particular when continuous veno-venous hemofiltration (CVVH) treatment is required. Considering the objective difficulty in enrolling this kind of patient, a preliminary study was initiated on seventeen septic shock patients admitted to a medical and surgical ICU. The mRNA expression of Toll-like receptor (TLR)-1, TLR-2, TLR-4, TLR-5, TLR-9, TNFalpha, IL-8 and IL-1beta was assessed, the plasmatic concentrations of IL-18, IL-2, IL-10 and TNFalpha were measured on the day of sepsis diagnosis and after 72 h. In those patients who developed acute renal failure unresponsive to medical treatment and who underwent CVVH treatment the same parameters were measured every 24 h during CVVH and after completion of the treatment. On sepsis diagnosis, gene expression of TLRs was up-regulated compared to the housekeeping gene in all the patients. After 72 h, in 35&#x0025; of the patients a down-regulation of these genes was found compared to day 1, but it was not associated with a reduction of cytokine serum levels or improved clinical signs, better outcome or reduced mortality. After high volume hemofiltration treatment, cytokine serum levels and TLR expression were not significantly modified. In conclusion, considering the not numerous number of cases, from our preliminary study, we cannot certainly correlate TLR over-expression in septic shock patients with severity or outcome scores

Impact of resistance to thyroid hormone on thecardiovascular system in adults.

Sixteen untreated and asymptomatic RTH patients (eight males; aged 33 +/- 12 yr, range 21-45 yr) and 16 controls (nine males; aged 33 +/- 5 yr, range 24-42 yr) were enrolled. Clinical data, thyroid status, and echocardiographic results were recorded.Our results suggest the presence of cardiovascular alterations in asymptomatic and untreated RTH patients similar to those reported in hypothyroid patients. Our strict selection likely created a bias in the inclusion of a particular type of RTH patients, who could represent a minority of patients with RTH. However, no correlation was found between the type of mutation and cardiovascular characteristics of RTH patient

Eo-Alpine HP metamorphism in the Permian intrusives from the steep belt of the central Alps (Languard-Campo nappe and Tonale Series)

Diorites and granitoids that intruded the Upper Austroalpine units of the central Alps during the Permian display mappable tectonic imprints and metamorphic transformations that were acquired during the Alpine tectonometamorphic cycle. Superposed heterogeneous deformations interacted with metamorphic re-equilibration stages and created a range of textural types that reflect local deformation gradients: coronitic transformations textures, normally foliated S-tectonites and mylonitic foliations. The three textural types are distinguished on maps recording foliation trajectories of successive deformation phases, which are correlated to the evolution of metamorphic assemblages. Tectonic deformation of Alpine age is represented by three generations of ductile syn-metamorphic structures. The mineral assemblages stable during the first Alpine deformation phase (DI) are Amp(II) + Pl(II) + white mica(I) + Zo/Czo + Grt + Qtz \ub1 Mg-Chl \ub1 Ilm in metadiorites and Pl(II) + white mica(I) + Zo/Czo + Grt + Amp(II) + Qtz \ub1 Ilm/Ttn in metagranitoids; the successive foliations D2a and D2b are defined by greenschist facies minerals. Thermobarometric estimates allow T = 500-600 \ub0C and P = 1.1 \ub1 0.2 GPa conditions to be determined during D1 and T 64 350 \ub0C and P 64 0.5 GPa during D2. Relict igneous minerals in metadiorites allow to determine intrusive conditions of T = 879 \ub1 110 \ub0C and P = 0.4-0.7 GPa. Radiometric ages and P/T ratio of Alpine P(max) T(Pmax) suggest that the inferred P-T-d-t path may represent the thermal state of the initial Alpine subduction stages. (C) 2000 Editions scientifiques et medicales Elsevier SAS

Adjuvant treatment withthyrotropin alpha for remnant ablation in thyroid cancer.

Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was approved in Europe for the radioiodine ablation of low-risk differentiated thyroid cancer (DTC) during thyroid hormone therapy with L-thyroxine (L-T4). Moreover, in December 2007, the US Federal Drug Administration approved the use of rhTSH for adjuvant treatment with radioiodine in patients with DTC without evidence of metastatic thyroid cancer. Quality of life was found to be better with rhTSH preparation than with L-thyroxine withdrawal, thereby resulting in benefits for society as a whole. Furthermore, rhTSH for radioiodine remnant ablation results in a longer effective radioiodine half-life within remnant thyroid tissue and a lower specific absorbed dose in the blood and exposure of bone marrow to X-rays. More studies are required to establish the amount of radioiodine to be administered especially in high-risk patients